NPA draws up training ahead of pseudoephedrine decision
A training programme to raise awareness of issues around the potential misuse of pseudoephedrine- and ephedrine-containing products is being prepared by the National Pharmacy Association.
The programme will be released as soon as possible after the Government
decides what additional restrictions around pseudoephedrine supply are
to be put in place.
The decision to prepare an awareness-training programme comes after the
NPA looked at measures taken internationally to help lessen the risk
of pseudoephedrine and ephedrine sold from pharmacies being used as a
precursor for methylamphetamine. In the US, there is an obligation under
federal law for staff working for general retailers and pharmacies to
undertake awareness training.
Colette McCreedy, the NPA’s acting chief executive, commented: “We
are sending a strong message to Government and stakeholders that the
NPA is prepared to invest in solutions that further reduce the risk of
pharmacy-supplied pseudoephedrine being used to produce methylamphetamine.”
The content of the training programme will meet a specification agreed
by the NPA, the Company Chemists’ Association, the Association
of Independent Multiples and the Royal Pharmaceutical Society, with input
from the Proprietary Association of Great Britain and pharmaceutical
manufacturers.
|
The
Pharmaceutical Journal
Acrobat
Reader